Deepak Sabharwal and Iana Malasevskaia (2026) “Role of PCSK9 Inhibitors in Contemporary Lipid-Lowering Era: A Systematic Review of LDL-C Reduction, Cardiovascular Outcomes, and Use in Statin-Intolerant and Very-High-Risk Patients”, Journal For International Medical Graduates, 5(1). doi:10.56570/hkdzy418.